Lillian Frohlich

Lillian (Lilly) Frohlich is a seasoned clinical operations professional with extensive experience in leading clinical trial management and operations in the biopharmaceutical industry. Currently serving as Sr. Director of Clinical Operations at Merida Biosciences, Lilly previously held leadership roles at AbbVie and Cerevel Therapeutics. Notable contributions include overseeing multiple Phase I and III studies, managing vendor relationships, and implementing process improvements in clinical trial operations. With a Master of Public Health in Epidemiology from Boston University School of Public Health and a Bachelor of Applied Science in Public Health from Syracuse University, Lilly has a strong academic foundation supporting a robust career dedicated to enhancing clinical research excellence.